Double Diffusion Encoding MRI for the Clinic

Por Yang, Grant, Tian, Qiyuan, Leuze, Christoph, Wintermark, Max, McNab, Jennifer
Publicado no Magn Reson Med (2017)

A study comparing the experiences of family and friends of young people with borderline personality...

Por Mirra R. Seigerman, Jennifer K. Betts, Carol Hulbert, Ben McKechnie, Victoria K. Rayner, Martina Jovev, Sue M. Cotton, Louise McCutcheon, Catharine McNab, Emma Burke, Andrew M. Chanen
Publicado em 2020-07-01

A psychoeducational group intervention for family and friends of youth with borderline personality...

Por Betts, Jennifer, Pearce, Jessie, McKechnie, Ben, McCutcheon, Louise, Cotton, Sue M., Jovev, Martina, Rayner, Victoria, Seigerman, Mirra, Hulbert, Carol, McNab, Catharine, Chanen, Andrew M.
Publicado no Borderline Personal Disord Emot Dysregul (2018)

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)

Por Blais, Normand, Hirsh, Vera
Publicado em 2014

nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

Por Ajeet Gajra, Nagla Abdel Karim, Deborah A. Mulford, Liza Cosca Villaruz, Marc Ryan Matrana, Haythem Y. Ali, Edgardo S. Santos, Tymara Berry, Teng Jin Ong, Alexandra Sanford, Katayoun Amiri, David R. Spigel
Publicado em 2018-07-01

Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin...

Por Yardley, Denise A., Brufsky, Adam, Coleman, Robert E., Conte, Pierfranco F., Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A., O’Shaughnessy, Joyce, Beck, Robert M., Ko, Amy, Renschler, Markus F., Barton, Debora, Harbeck, Nadia
Publicado no Trials (2015)

A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine...

Por Yang, Jin-Ji, Huang, Cheng, Chen, Gong-Yan, Song, Yong, Cheng, Ying, Yan, Hong-Hong, Zhou, Qing, Wu, Yi-Long
Publicado em 2014

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval

Por Yamamoto, Yutaka, Kawano, Ichiro, Iwase, Hirotaka
Publicado em 2011

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval

Por Iwase H, Kawano I, Yamamoto Y
Publicado em 2011-07-01

Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer

Por Socinski, M.A.
Publicado em 2014

Sequential nearest-neighbor effects on computed (13)C(α) chemical shifts

Por Vila, Jorge A., Serrano, Pedro, Wüthrich, Kurt, Scheraga, Harold A.
Publicado em 2010

Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma

Por Diamandis, Phedias, Ferrer-Luna, Ruben, Huang, Raymond Y., Folkerth, Rebecca D., Ligon, Azra H., Wen, Patrick Y., Beroukhim, Rameen, Ligon, Keith L., Ramkissoon, Shakti H.
Publicado no Diagn Pathol (2016)

LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays

Por Piehler, Britt, Nelson, Elizabeth K, Eckels, Josh, Ramsay, Sarah, Lum, Karl, Wood, Blake, Greene, Kelli M, Gao, Hongmei, Seaman, Michael S, Montefiori, David C, Igra, Mark
Publicado em 2011

Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants

Por Lai, Rachel P. J., Seaman, Michael S., Tonks, Paul, Wegmann, Frank, Seilly, David J., Frost, Simon D. W., LaBranche, Celia C., Montefiori, David C., Dey, Antu K., Srivastava, Indresh K., Sattentau, Quentin, Barnett, Susan W., Heeney, Jonathan L.
Publicado em 2012

Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel

Por MURAKAMI, TAKASHI, MURATA, TAKUYA, KAWAGUCHI, KEI, KIYUNA, TASUKU, IGARASHI, KENTARO, HWANG, HO KYOUNG, HIROSHIMA, YUKIHIKO, HOZUMI, CHIHIRO, KOMATSU, SHIN, KIKUCHI, TAKASHI, LWIN, THINZAR M., DELONG, JONATHAN C., MIYAKE, KENTARO, ZHANG, YONG, TANAKA, KUNIYA, BOUVET, MICHAEL, ENDO, ITARU, HOFFMAN, ROBERT M.
Publicado no Anticancer Res (2017)

Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study

Por Xu, Ruihua, Yu, Xianjun, Hao, Jihui, Wang, Liwei, Pan, Hongming, Han, Guohong, Xu, Jianming, Zhang, Yanqiao, Yang, Shujun, Chen, Jia, Ying, Jieer, Dai, Guanghai, Li, Mingyu, Begic, Damir, Lu, Brian, Shen, Lin
Publicado no BMC Cancer (2017)

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors

Por Mathew, Shilu, Al Thani, Asmaa A., Yassine, Hadi M.
Publicado no PLoS One (2018)

Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro.

Por Kent, M J, Light, N D, Bailey, A J
Publicado em 1985

Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel...

Por Tabernero, Josep, Chiorean, E. Gabriela, Infante, Jeffrey R., Hingorani, Sunil R., Ganju, Vinod, Weekes, Colin, Scheithauer, Werner, Ramanathan, Ramesh K., Goldstein, David, Penenberg, Darryl N., Romano, Alfredo, Ferrara, Stefano, Von Hoff, Daniel D.
Publicado no Oncologist (2015)

“Stealth” Adenoviruses Blunt Cell-Mediated and Humoral Immune Responses against the Virus and Allow for Significant Gene Expression upon Readministration in the Lung

Por Croyle, Maria A., Chirmule, Narendra, Zhang, Yi, Wilson, James M.
Publicado em 2001